A real world retrospective cohort study to compare risk of cardiovascular-related hospitalizations and death among Atrial fibrillation/Atrial flutter patients treated with dronedarone versus other antiarrhythmic drugs
Latest Information Update: 02 Sep 2020
At a glance
- Drugs Dronedarone (Primary) ; Amiodarone; Antiarrhythmics; Dofetilide; Flecainide; Propafenone; Sotalol
- Indications Arrhythmias; Atrial fibrillation; Atrial flutter; Cardiovascular disorders
- Focus Therapeutic Use
- 31 Aug 2020 Primary endpoint (hospitalization for cardiovascular causes within 24 months after the first study drug fill) has been met, according Results published in the American Journal of Cardiology
- 31 Aug 2020 New trial record
- 27 Aug 2020 Results published in the American Journal of Cardiology